| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73b46a19d9635f31a98d8919333159f4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6740612fcf21a9168f1d54a62bc6c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e80995cc3f3a19982c6592577e4e424 |
| publicationDate |
2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2241634-A1 |
| titleOfInvention |
Diagnostic method and tools to predict the effiacy of targeted agents against IGF-1 pathway activation in cancer |
| abstract |
The present invention relates to a gene set, kit and method to predict the efficacy of IGF-1 pathway inhibitors in cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012106556-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013079188-A1 |
| priorityDate |
2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |